Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel/Carboplatin/Bevacizumab vs Paclitaxel/Carboplatin/Temsirolimus vs Ixabepilone/Carboplatin/Bevacizumab in Advanced Endometrial Cancer
NCT00977574Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2009
- Primary completion
- Jan 2015
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin, bevacizumab, temsirolimus, ixabepilone in endometrial cancer (EC), sponsored by National Cancer Institute. Started Sep 2009; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatinbevacizumabtemsirolimusixabepilone
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00977574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977574.